Skip to main content
SpringerLink
Log in

Apo A-I Containing Particles and Atherosclerosis

  • Chapter
Cardiovascular Disease

  • 89 Accesses

Abstract

Epidemiological and clinical studies showing an association between decreased concentrations of high-density-lipoprotein (HDL) cholesterol and increased risk of premature coronary artery disease (CAD)1,2 have generated interest in the mechanism through which HDL prevents atherosclerosis. The HDL have been historically defined as lipoproteins with densities between 1.063 and 1.20 g/ml3. Human HDL consists of a collection of particles differing in size, density and apolipoprotein content4. Over the years, ultracentrifugation and, subsequently, polyanion precipitation and gradient gel electrophoresis have been used to fractionate HDL into subclasses5. Recognition of the importance of the apolipoproteins (apo) not only in the formation and structural stability of lipoproteins but also in their metabolism has led to the separation of HDL into further subpopulations according to their apolipoprotein composition rather than their physicochemical properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber, High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study, Am. J. Med. 62:707 (1977).

    Article  PubMed  CAS  Google Scholar 

  2. N.E. Miller, O.H. Forte, D.S. Thelle, and O.D. Mjos, The Tromso heart study: high density lipoprotein and coronary heart disease: a prospective case control study, Lancet i:965 (1977).

    Article  Google Scholar 

  3. R.J. Havel, H.A. Eden, and J.H. Bragdon, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest. 34:1345 (1955).

    Article  PubMed  CAS  Google Scholar 

  4. P. Alaupovic, The physicochemical and immunological heterogeneity of human plasma high density lipoproteins, in: “Clinical and Metabolic Aspects of High-Density Lipoproteins”, N.E. Miller, G.J. Miller, eds., Elsevier Science Publishers B.V., Amsterdam (1985).

    Google Scholar 

  5. J.C. Fruchart, S. Marcovina, and P. Puchois, Laboratory measurements of plasma lipids and lipoproteins, in: “Human Plasma Lipoprotein”, J.C. Fruchart, J. Shepherd, eds., Walter de Gruyter, Berlin (1989).

    Google Scholar 

  6. M.C. Cheung, and J.J. Albers, Characterization of lipoprotein particles isolated by immunoaffmity chromatography: particles containing A-I and A-II and particles containing A-I but not A-II, J. Biol. Chem. 259:12201 (1984).

    PubMed  CAS  Google Scholar 

  7. T. Ohta, S. Hattori, S. Nishiyama, and I. Matsuda, Studies on the lipid and apolipoprotein compositions of two species of apo A-I containing lipoproteins in normolipidemic males and females, J. Lipid Res. 29:721 (1988).

    PubMed  CAS  Google Scholar 

  8. P. Alaupovic, E.D. Bekaert, and E. Koren, Isolation, characterization and quantitation of subclasses of plasma lipoproteins defined by their apolipoprotein composition, Atherosclerosis Rev. 20:179 (1990).

    Google Scholar 

  9. M.C. Cheung, A.C. Wolf, K.D. Lum, J.H. Tollefson, and J.J. Albers, Distribution and localization of lecithin: cholesteryl acyl-transferase and cholesteryl ester transfer activity in apo A-I containing lipoproteins, J. Lipid Res. 27:1135 (1986).

    PubMed  CAS  Google Scholar 

  10. H.V. De Silva, W.D. Stuart, and C.R. Duvic, A 70-kDa apolipoprotein designated apo J is a marker for subclasses of human plasma high density lipoproteins, J. Biol. Chem. 265:13240 (1990).

    PubMed  Google Scholar 

  11. H.B. Brewer, D. Rader, S. Fojo, and J.M. Hoeg, Frontiers in the analysis of HDL structure, function, and metabolism, in: “Disorders of HDL”, L.A. Carlson, ed., Smith-Gordon and Company Ltd, London (1990).

    Google Scholar 

  12. D. Rader, J.R. Schaefer, M.R. Kindt, L.A. Zecht, J.C. Fruchart, and H.B. Brewer, Differential in vivo metabolism of HDL subclasses LpA-I and LpAI:A-II in man, Clin. Res. 38:204A (1990).

    Google Scholar 

  13. A. Barkia, P. Puchois, N. Ghalim, G. Torpier, G. Ailhaud, and J.C. Fruchart, Differential role of apolipoprotein A-I containing particles in cholesterol efflux from adipose cells, Atherosclerosis 87:135 (1991).

    Article  PubMed  CAS  Google Scholar 

  14. A. Steinmetz, R. Barbaras, N. Ghalim, V. Clayey, J.C. Fruchart, and G. Ailhaud, Human apolipoprotein A-N binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells, J. Biol. Chem. 265:7859 (1990).

    PubMed  CAS  Google Scholar 

  15. R. Barbaras, P. Puchois, J.C. Fruchrt, A. Pradines-Figueres, and G. Ailhaud, Purification of an apolipoprotein A binding protein from mouse adipose cells, Biochem. J. 269:767 (1990).

    PubMed  CAS  Google Scholar 

  16. J.P. Slotte, J.F. Oram, and E.L. Bierman, Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface, J. Biol. Chem. 262:12904 (1987).

    PubMed  CAS  Google Scholar 

  17. N. Theret, C. Delbart, G. Aguie, J.C. Fruchart, G. Vassaux, and G. Ailhaud, Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation, Biochem. Biophys. Res. Commun. 173:1361 (1990).

    Article  PubMed  CAS  Google Scholar 

  18. S. Oikawa, A.J. Mendez, M.C. Cheung, J.F. Oram, and E.L. Bierman, Effect of apo A-I and apo A-I:A-II HDL particles in intracellular cholesterol efflux, Circulation (abstract) 84(suppl II):2711 (1991).

    Google Scholar 

  19. W.J. Johnson, E.P.C. Kilsdonk, A. Van Tol, M.C. Phillips, and G.H. Rothblat, Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LpA-I and LpA-I:A-II, J. Lipid Res. 32:1992 (1991).

    Google Scholar 

  20. M.C. Cheung, and J.J. Albers, Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but not A-II, J. Lipid Res. 23:747 (1982).

    PubMed  CAS  Google Scholar 

  21. R.F. Atmeh, J. Shepherd, and C.J. Packard, Subpopulations of apolipoprotein A-I in human high density lipoproteins. Their metabolisms properties and response to drug therapy, Biochim. Biophys. Acta 751:175 (1983).

    Article  PubMed  CAS  Google Scholar 

  22. E. Koren, P. Puchois, P. Alaupovic, J. Fesmire, A. Kandoussi, and J.C. Fruchart, Quantification of two types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential antibody immunosorbent assay, Clin. Chem. 33:38 (1987).

    PubMed  CAS  Google Scholar 

  23. H.J. Parra, H. Mezdour, N. Ghalim, J.M. Bard, and J.C. Fruchart, Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates, Clin. Chem. 36:1431 (1990).

    PubMed  CAS  Google Scholar 

  24. G. Luc, J.M. Bard, S. Lussier-Cacan, S. Bouthillier, H.J. Parra, J.C. Fruchart, and J. Davignon, High-density lipoprotein particles in octogenarians, Metabolism 40:1238 (1991).

    Article  PubMed  CAS  Google Scholar 

  25. P. Puchois, A. Kandoussi, P. Fiévet, J.L. Fourrier, M. Bertrand, E. Koren, and J.C. Fruchart, Apolipoprotein A-I containing lipoproteins in coronary artery disease, Atherosclerosis 68:35 (1987).

    Article  PubMed  CAS  Google Scholar 

  26. J.J. Genest, J.M. Bard, J.C. Fruchart, J.M. Ordovas, P.F.W. Wilson, and G.J. Shaefer, Plasma apolipoproteins (a), A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease, Atherosclerosis 90:149 (1991).

    Article  PubMed  Google Scholar 

  27. F. Cambien, H.J. Parra, D. Arveiler, J.P. Cambou, A. Evans, A. Bingham, Lipoprotein particles in patients with myocardial infarction and controls, Circulation 82(Supp1 III):348 (1990).

    Google Scholar 

  28. P. Amouyel, D. Isorez, J.M. Bard, M. Goldman, P. Lebel, G. Zylberberg, and J.C. Fruchart, Parenteral history of early myocardial infarction is associated with decreased levels of lipoparticle A-I in adolescents, Arterioscl. Thromb. 13:1640 (1193).

    Article  Google Scholar 

  29. S. Lussier-Cacan, J.M. Bard, L. Boulet, A.C. Nestruck, A.M. Grother, J.C. Fruchart, and J.C. Fruchart, and J. Davignon, Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III, Atherosclerosis 78:167 (1989).

    Article  PubMed  CAS  Google Scholar 

  30. C. Cachera, A. Kandoussi, K. Equagoo, J.C. Fruchart, and A. Tacquet, Evaluation of apolipoprotein A-I containing particles in chronic renal failure patients undergoing hemodialysis, Am. J. Nephrol. 10:171 (1990).

    Article  PubMed  CAS  Google Scholar 

  31. J.C. Fruchart, Insulin resistance and lipoprotein abnormalities, Diabete Metab. 17:244 (1991).

    PubMed  CAS  Google Scholar 

  32. F. Fumeron, L. Brigant, H.J. Parra, J.M. Bard, J.C. Fruchart, and M. Apfelbaum, Lowering of HDL2 cholesterol and lipoprotein A-I particle levels by increasing the ratio of polyunsaturated to saturated fatty acids, Am. J. Clin. Nutr. 53:655 (1991).

    PubMed  CAS  Google Scholar 

  33. P. Puchois, N. Ghalim, G. Zylberberg, P. Fiévet, C. Demarquilly, and J.C. Fruchart, Effect of alcohol intake on human apolipoprotein A-I containing lipoprotein subfractions, Arch. Intern. Med. 150:1638 (1990).

    Article  PubMed  CAS  Google Scholar 

  34. J.M. Bard, H.J. Parra, R. Camare, G. Luc, O. Ziegler, C. Dachet, E. Bruckert, P. Douste-Blazy, P. Drouin, B. Jacotot, J.L. De Gennes, U. Keller, and J.C. Fruchart, A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition, Metabolism 4:498 (1992).

    Article  Google Scholar 

  35. J.M. Bard, H.J. Parra, P. Douste-Blazy, and J.C. Fruchart, Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition, Metabolism 39:269 (1990).

    Article  PubMed  CAS  Google Scholar 

  36. J.C. Fruchart, C. De Geitère, B. Delfly, G.R. Castro - Unpublished results.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Pasteur 1, SERLIA & Unité INSERM 325, rue du Professeur Calmette, 59019, Lille Cédex, France

    Jean-Charles Fruchart, Graciela Castro & Patrick Duriez

Authors
  1. Jean-Charles Fruchart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graciela Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Duriez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The George Washington University Medical Center, Washington, D.C., USA

    Linda L. Gallo

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fruchart, JC., Castro, G., Duriez, P. (1995). Apo A-I Containing Particles and Atherosclerosis. In: Gallo, L.L. (eds) Cardiovascular Disease. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1959-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1959-1_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5805-3

  • Online ISBN: 978-1-4615-1959-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation